Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Wilhelm

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Circulation Research|April 19, 2024
GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary HypertensionXuran Chu, Vahid Kheirollahi, Arun Lingampally, et al.
Chest|March 20, 2024
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Henning Gall, Meike Fünderich, et al.
Pulmonary Circulation|August 29, 2022
Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centersRaphael W Majeed, Martin R Wilkins, Luke Howard, et al.
Nature Metabolism|July 23, 2020
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
Nature Metabolism|July 23, 2020
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
EMBO Molecular Medicine|October 18, 2021
Flower lose, a cell fitness marker, predicts COVID-19 prognosisMichail Yekelchyk, Esha Madan, Jochen Wilhelm, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
Sleep and Vigilance|March 23, 2022
Scientists Against War: A Plea to World Leaders for Better GovernanceSeithikurippu R Pandi-Perumal, Velayudhan Mohan Kumar, Namasivayam Ganesh Pandian, et al.
Nature Biotechnology|December 9, 2024
Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cellsEsha Madan, António M Palma, Vignesh Vudatha, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Circulation Research|April 19, 2024
GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary HypertensionXuran Chu, Vahid Kheirollahi, Arun Lingampally, et al.
Chest|March 20, 2024
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Henning Gall, Meike Fünderich, et al.
Pulmonary Circulation|August 29, 2022
Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centersRaphael W Majeed, Martin R Wilkins, Luke Howard, et al.
Nature Metabolism|July 23, 2020
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
Nature Metabolism|July 23, 2020
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
EMBO Molecular Medicine|October 18, 2021
Flower lose, a cell fitness marker, predicts COVID-19 prognosisMichail Yekelchyk, Esha Madan, Jochen Wilhelm, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
Sleep and Vigilance|March 23, 2022
Scientists Against War: A Plea to World Leaders for Better GovernanceSeithikurippu R Pandi-Perumal, Velayudhan Mohan Kumar, Namasivayam Ganesh Pandian, et al.
Nature Biotechnology|December 9, 2024
Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cellsEsha Madan, António M Palma, Vignesh Vudatha, et al.
Pageof 19